Langerhans’ cells and L1 antigen expression in normal and abnormal squamous epithelium of the cervical transformation zone

Gynecologic and Obstetric Investigation

Volumn 41, Issue 3, 1996, Pages 207-213

  Poppe, W A J ^a   Drijkoningen, M ^a   Ide, P S ^a   Lauweryns, J M ^a   Van Assche, F A ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Cervical intraepithelial neoplasia; Immunohistochemistry; L1 antigen; Langerhans cells; Pregnancy; Smoking

Indexed keywords

CALGRANULIN;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CELL COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; LANGERHANS CELL; PREGNANCY; PRIORITY JOURNAL; PUNCH BIOPSY; SMOKING; SQUAMOUS EPITHELIUM; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX EPITHELIUM;

ADULT; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; EPITHELIUM; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LANGERHANS CELLS; LEUKOCYTE L1 ANTIGEN COMPLEX; MIDDLE AGED; NEOPLASMS, SQUAMOUS CELL; NEURAL CELL ADHESION MOLECULES; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; SMOKING; UTERINE CERVICAL NEOPLASMS;

EID: 0029963804     PISSN: 03787346     EISSN: 1423002X     Source Type: Journal    
DOI: 10.1159/000292270     Document Type: Article

References (45)

1. Richart RM: Cervical intraepithélial neoplasia: A review: in Sommers SC (ed): Pathology Annual. New York. Appleton-Century-Crofls. 1973. pp 301-328.
2. Tamaki K, Stingl G, Katz S: The origin ofLan-gerhans' cells. J Invest Dermatol 1980:74:309-311.
3. Stingl G. Katz SI. Clement L. Green I, Shevach EM: Immunological functions of la bearing epidermal Langerhans-cells. J Immunol 1978: 121:2005-2008.
4. Epstein AL, Marder RJ. Winter J. Fox RL: Two new monoclonal antibodics(LN-l. LN-2) reactive in B5 fixed paraffin embedded tissues with follicular center and mantle z., one human 13 lymphocytes and derived tumors. J Immunol 1984:133:1028-1036.
5. KJigman D. Hilt DC: The S100 protein family. Trends Biochcm Sei 1988:13:437-443.
6. Puts JJG. Moekser O. de Waal RMW. Kerrc-mans P. Vooijs GP. Ramackers FCS: Immuno-histochcmical investigation of Langerhans" cells in normal epithelium and in epithelial lesions of the uterine cervix. Int J Gvnecol Pathol 1986:5:151-162.
7. Tav SK. Jenkins D. Maddox P. Campion M. Singer A: Subpopulations of Langerhans' cells in cervical neoplasia. Br J Obstet Gvnaecol 1987:94:10-15.
8. Hughes RG. Norval M. Howie SEM: Expression of major histocompatibility class II antigens by Langerhans" cells in cervical intraepithelial neoplasia. J Clin Pathol 1988:41:253-259.
9. Barton SE. Jenkins D, Cuzick J. Maddox PH, Edwards R. Singer A: Effect of cigarette smoking on cervical epithelial immunity: A mechanism for neoplastic change"? Lancet 1988;Vol ii: 652-654.
10. Hawthorn RJ. Murdoch JB. Mac Lean AB, Mac Kie RM: Langerhans’ cells and subtypes of human papillomavirus in cervical intraepithélial neoplasia. BMJ 1988:297:643-646.
11. Viac J. Guerin-Revcrchon I. Chardonnet Y, Brcmond A: Langerhans" cells and epithelial cell modifications in cervical intraepithélial neoplasia: Correlation with human papillomavirus infection. Immunobiology 1990:180: 328-338.
12. Morris HHB. Gatter KC. Stein H. Mason DY: Langerhans" cells in human cervical epithelium: An immunohistoehcmical study. Br J Obstet Gynaecol 1983:90:400-411.
13. Me Ardle JP. Muller HK: Quantitative assessment of Langerhans" cells in human cervical intraepithélial neoplasia and wart virus infection. Am J Obstet Gynecol 1986:154:509-515.
14. Chomettc G. Tranbaloc P. Auriol M. Coupez F. Blondon J: Cellules de Langerhans" et lymphocytes T dans les dvsplasies et cancers du col utcrin. Arch Anat Cytol Pathol 1988:36:212-217.
15. Winkelstein W Jr: Smoking and cervical cancer-current status: A review. Am J Epidemiol 1990:131:945-957.
16. SchifTman MH. Bauer HM. Hoover RN. Glass AG. Cadell DM. Rush BB. Scott DR. Sherman ME. Kurman RJ. Sacholder S, Stanton CR, Manos MM: Epidemiologic evidence showing that human papillomavirus infection causes most cervical intracpithclial neoplasia. J Natl Cancer Inst 1993:85:958-964.
17. Bosch FX, Munoz N. De Sanjose S. izarzugaza I. Gili M. Viladiu P. Tormo MJ. Moreo P. Ascunce N. Gonzalez LC. Tafur L. Kaldor JM. Guerrero E. Aristizabal N. Santamaria M. Alonso de Ruiz P. Shah K: Risk factors for cervical cancer in Columbia and Spain. Int J Cancer 1992:52:750-758.
18. Brandtzaeg P. Dale L. Gabrielsen TO: The leucocyte protein LI (calprotectin): Usefulness as an inimunohistochemical marker antigen and putative biological function. Histopathology 1992:21:191-196.
19. Gabrielsen TO. Brandtzaeg P. Hocl PS. Dale I: Epithelial distribution of a myclomonocvtic antigen LI in relation to cutaneous malignancies and mclanocytic nacvi. Br J Dermatol 1988:118:59-67.
20. Watanabe Y. Jacob CO: Regulation of MHC class II antigen expression. Opposing effects of tumor necrosis factor a on IFN-y induced HLA-DR and la expression depends on the maturation and differentiation stage of the cell. J Immunol 1991:146:899-905.
21. Brandtzaeg P. Dale I. Fagcrhol MK: Distribution of a formalin-resistant myelomonocytic antigen (LI) in human tissues. II. Normal and aberrant occurrence in various epithclia. Am J Clin Pathol 1987:87:700-707.
22. Murao S. Collart FR. Huberman E: A protein containing the cystic fibrosis antigen is an inhibitor of protein kinases. J Biol Chcm 1989: 264:8356-8360.
23. Coleman N. Stanley MA: Expression of the myelomonocytic antigensCD36and LI by kératinocytes in squamous intraepithélial lesions of the cervix. Hum Pathol 1994:25:73-79.
24. Bauer HM. Greer CE. Chambers JC. Tashiro CJ. Cimera J. Reingold A. Manos MM: Genital human papillomavirus infection in female university students as determined by a PCR-based method. JAMA 1991:265:472-477.
25. Schneider A: Pathogenesis of genital HPV infection. Genitourin Med 1993:69:165-173.
26. De Villiers EM. Wagner D. Schneider A. Wesch H. Munz F, Miklaw H, zur Hausen H: Human papillomavirus DNA in women with and without cytological abnormalities: Results of a five-year follow-up study. Gynecol Oncol 1992:44:33-39.
27. Schneider A, Kirckhof TT, Mcinhardt G. Giss-mann L: Repeated evaluation of human papillomavirus 16 status in cervical swabs of young women with a history of normal Papanicolaou smears. Obstet Gynecol 1992:79:683-688.
28. Rando RF. Lindheim S. Hasty L. Sedlacek TV, Woodland M. Eder C: Increased frequency of detection of human papillomavirus deoxyribonucleic acid in exfoliated cervical cells during pregnancy. Am J Obstet Gynecol 1989:161:50-55.
29. Kemp EA. Hakencwerth AM. Laurent SL, Gravitt PE, Stoerker J: Human papillomavirus prevalence in pregnancy. Obstet Gynecol 1992; 79:649-656.
30. Billington WD: The normal fetomatcrnal immune relationship. Baillieres Clin Obstet Gynaecol 1992:6:417-438.
31. Szekeres-Bartho J, Kilar F. Falkav G. Csernus V. Torok A, Pacsa AS: The mechanism of the inhibitory effect of progesterone on lymphocyte cytotoxicity. 1. Progesterone-treated lymphocytes release a substance inhibiting cytotoxicity and prostaglandin synthesis. Am J Reprod Immunol Microbiol 1985:9:15-18.
32. Ahmed SA, Penhale WJ, Talal N: Sex hormones, immune responses, and autoimmune diseases: Mechanisms of sex hormone action. Am J Pathol 1985:121:531-551.
33. Herrero R. Brinton LA. Reeves WC. Brenes MM. Tenorio F. Dc Britton RC, Gaitan E, Garcia M. Rawls WE: Invasive cervical cancer and smoking in Latin America. J Natl Cancer Inst 1989;81:205-211.
34. Poppe WA. Ide PS. Drijkoningcn MPG. Lau-weryns JM. Van Assche FA: Tobacco smoking impairs the local immunosurvcillance in the uterine cervix: An immunohistochemical study. Gynecol Obstet Invest 1995;39:34-38.
35. Caorsi I, Figueroa CD: Langerhans’ cell density in the normal exocervical epithelium and in the cervical intraepithelial neoplasia. Br J Obstet Gynaecol 1986:93:993-998.
36. de Jong MCJM. Blanken R. Nanninga J, Van Voorst Vader PC. Poppcma S: Defined in situ enumeration of Tö and HLA-DR expressing epidermal Langerhans' cells: Morphologic and methodological aspects. J Invest Dermatol 1986:87:698-702.
37. Sasson IM. Haley NJ. Hoffmann D, Wynder EL. Hellberg D, Nilsson S: Cigarette smoking and neoplasia of the uterine cervix: Smoke constituents in cervical mucus. N Engl J Med 1985:312:315-316.
38. Poppe WA. Peelers R. Dacnens P. Ide PS. Van Assche FA: Tobacco smoking and the uterine cervix: Cotinine in blood, urine and cervical fluid. Gynecol Obstet Invest 1995:39:110-114.
39. Simons AM. Phillips DH. Coleman DV: Damage to DNA in cervical epithelium related to tobacco smoking. BMJ 1993:306:1444-1448.
40. Drijkoningcn M. Dc Wolf-Pcctcrs C. Degrecf H, Desmct V: Epidermal Langerhans’ cells, dermal dendritic cells and keratinocvtcs in viral lesions of skin and mucous membranes: An immunohistochemical study. Arch Dermatol Res 1988:280:220-227.
41. Carson LF. Twiggs LB. Fukushima M. Ostrow RS. Faras AJ. Okagaki T: Human genital papilloma infections: An evaluation of immunologic competence in the genital neoplasia-papilloma syndrome. Am J Obstet Gynecol 1986:155: 784-789.
42. Canda R. Tyring SK. Grossi CE. Tildcn AB. Hatch KD, Sams WM. Baron S, Whitley RJ: Patients with condyloma accuminatum exhibit decreased interleukin-2 and interferon-gamma production and depressed natural killer activity. J Clin Immunol 1987;7:304-311.
43. Schneider V. Kay S. Lee HM: Immunosuppression as high risk factor in the development of condyloma accuminatum and squamous neoplasia of the cervix. Acta Cytol 1983:27:220-223.
44. Sohnle PG. Collins-Lech C. Wiessner JH: Antimicrobial activity of an abundant calcium-binding protein in the cytoplasm of human neutrophils. J Infect Dis 1991:163:187-192.
45. Heydcn A, Thrane PS, Brandtzaeg P: Loss of epithelial LI expression is associated with cellular invasion of oral squamous cell carcinomas. J Oral Pathol Med 1992:21:330-335.